Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Tyrosine-protein kinase JAK1 [574-1154] | ||
Ligand | BDBM493103 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Enzymatic Inhibition Assay | ||
IC50 | 0.200±n/a nM | ||
Citation | Bacani, GM; Chai, W; Koudriakova, T; Krawczuk, PJ; Kreutter, KD; Leonard, K; Rizzolio, MC; Seierstad, M; Smith, RC; Tichenor, MS; Venable, JD; Wang, A Imidazopyrrolopyridine as inhibitors of the JAK family of kinases US Patent US10981911 Publication Date 4/20/2021 | ||
More Info.: | Get all data from this article, Assay Method | ||
Tyrosine-protein kinase JAK1 [574-1154] | |||
Name: | Tyrosine-protein kinase JAK1 [574-1154] | ||
Synonyms: | JAK1 | JAK1 (aa 574-1154) | JAK1A | JAK1B | JAK1_HUMAN | ||
Type: | Protein | ||
Mol. Mass.: | 66641.39 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P23458[574-1154] | ||
Residue: | 581 | ||
Sequence: |
| ||
BDBM493103 | |||
n/a | |||
Name | BDBM493103 | ||
Synonyms: | 2-(1-((1r,4r)-4-(Cyanomethyl)cyclohexyl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-2-yl)-N-(2-(pyridin-4-yloxy)ethyl)acetamide | US10981911, Example 43 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H27N7O2 | ||
Mol. Mass. | 457.5276 | ||
SMILES | O=C(Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1)NCCOc1ccncc1 |r,wU:18.21,wD:15.17,(-2.41,-1.63,;-1.64,-.29,;-.1,-.29,;.67,-1.63,;.05,-3.03,;1.19,-4.06,;1.19,-5.6,;2.52,-6.37,;3.86,-5.6,;5.32,-6.08,;6.23,-4.83,;5.32,-3.59,;3.86,-4.06,;2.52,-3.29,;2.2,-1.79,;3.23,-.64,;4.74,-.96,;5.77,.18,;5.29,1.64,;6.33,2.79,;7.83,2.47,;9.34,2.15,;3.79,1.97,;2.76,.82,;-2.41,1.04,;-3.95,1.04,;-4.72,2.37,;-6.26,2.37,;-7.03,3.71,;-6.26,5.04,;-7.03,6.37,;-8.57,6.37,;-9.34,5.04,;-8.57,3.71,)| | ||
Structure |